Rafael Castellanos-Bueno , Alín Abreu-Lomba , Nathalia Buitrago-Gómez , Marcela Patiño-Arboleda , Doly Pantoja-Guerrero , Alex Valenzuela-Rincón , Henry M. Arenas-Quintero , Humberto I. Franco-Betancur , Alejandro Castellanos-Pinedo , Dinett Movilla-Castro , José M. Ocampo-Chaparro , Carlos A. Reyes-Ortiz , Alejandro Pinzón-Tovar
{"title":"Clinical and epidemiological characteristics, morbidity and treatment based on the registry of acromegalic patients in Colombia: RAPACO","authors":"Rafael Castellanos-Bueno , Alín Abreu-Lomba , Nathalia Buitrago-Gómez , Marcela Patiño-Arboleda , Doly Pantoja-Guerrero , Alex Valenzuela-Rincón , Henry M. Arenas-Quintero , Humberto I. Franco-Betancur , Alejandro Castellanos-Pinedo , Dinett Movilla-Castro , José M. Ocampo-Chaparro , Carlos A. Reyes-Ortiz , Alejandro Pinzón-Tovar","doi":"10.1016/j.ghir.2021.101425","DOIUrl":null,"url":null,"abstract":"<div><h3>Aims</h3><p>Describe the local characteristics, methodology and results of the registry of acromegalic patients in Colombia (RAPACO).</p></div><div><h3>Methods</h3><p>Multicenter, retrospective study based on the registry of acromegalic patients in Colombia: RAPACO. The data collected included: demographics, diagnosis, approximate time of disease evolution, data on weight, height, body mass index<span><span> (BMI), neck circumference<span> (NC) abdominal circumference<span> (AC) hip circumference (HC) and waist/hip ratio (WHR); clinical and biochemical data at the time of diagnosis, etiology, </span></span></span>immunohistochemistry<span> of the tumor and information related to types of treatment. Descriptive analytics were employed.</span></span></p></div><div><h3>Results</h3><p>A total of 201 patients (60% females) with an average age at registration of 49.5 ± 14.6 years and an average time of evolution of the disease of 6.96 ± 4.5 years. Average weight was 75.1 Kg ± 12.98, with an average BMI of 28.11 ± 4.33. The most frequent symptoms mentioned at the time of diagnosis were extremity enlargement and headache. The most frequent comorbidity was arterial hypertension in 50.3% of the cases. 78.6% of cases were caused by macroadenoma<span>. 80.1% received surgical treatment, 77.6% were under medical treatment, of which 95.7% were receiving somatostatin analogues. 26.4% of patients were treated with radiation therapy. Of the patients who received any type of clinical treatment, only 2.5% reported biochemical control at registration.</span></p></div><div><h3>Conclusion</h3><p>It is important to recognize the local epidemiological, clinical, biochemical and treatment characteristics in order to assist in further understanding this pathology to implement local measures to improve both the quality of life as well as the prognosis of the patients diagnosed.</p></div>","PeriodicalId":12803,"journal":{"name":"Growth Hormone & Igf Research","volume":"60 ","pages":"Article 101425"},"PeriodicalIF":1.6000,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ghir.2021.101425","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Growth Hormone & Igf Research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1096637421000484","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 2
Abstract
Aims
Describe the local characteristics, methodology and results of the registry of acromegalic patients in Colombia (RAPACO).
Methods
Multicenter, retrospective study based on the registry of acromegalic patients in Colombia: RAPACO. The data collected included: demographics, diagnosis, approximate time of disease evolution, data on weight, height, body mass index (BMI), neck circumference (NC) abdominal circumference (AC) hip circumference (HC) and waist/hip ratio (WHR); clinical and biochemical data at the time of diagnosis, etiology, immunohistochemistry of the tumor and information related to types of treatment. Descriptive analytics were employed.
Results
A total of 201 patients (60% females) with an average age at registration of 49.5 ± 14.6 years and an average time of evolution of the disease of 6.96 ± 4.5 years. Average weight was 75.1 Kg ± 12.98, with an average BMI of 28.11 ± 4.33. The most frequent symptoms mentioned at the time of diagnosis were extremity enlargement and headache. The most frequent comorbidity was arterial hypertension in 50.3% of the cases. 78.6% of cases were caused by macroadenoma. 80.1% received surgical treatment, 77.6% were under medical treatment, of which 95.7% were receiving somatostatin analogues. 26.4% of patients were treated with radiation therapy. Of the patients who received any type of clinical treatment, only 2.5% reported biochemical control at registration.
Conclusion
It is important to recognize the local epidemiological, clinical, biochemical and treatment characteristics in order to assist in further understanding this pathology to implement local measures to improve both the quality of life as well as the prognosis of the patients diagnosed.
期刊介绍:
Growth Hormone & IGF Research is a forum for research on the regulation of growth and metabolism in humans, animals, tissues and cells. It publishes articles on all aspects of growth-promoting and growth-inhibiting hormones and factors, with particular emphasis on insulin-like growth factors (IGFs) and growth hormone. This reflects the increasing importance of growth hormone and IGFs in clinical medicine and in the treatment of diseases.